Therefore, the increased sLOX-1 levels in this younger SLE population may reflect subclinical atherosclerosis and the enhanced risk of CVD which is consistent with high sLOX-1 levels associated with higher hsCRP, oxLDL and impaired HDL functionality. Here, OLR1 is linked to systemic lupus erythematosus.